These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7859023)

  • 1. Treatment of hyperlipidemia in chronic progressive renal disease.
    Kasiske BL; O'Donnell MP; Kim Y; Keane WF
    Curr Opin Nephrol Hypertens; 1993 Jul; 2(4):602-8. PubMed ID: 7859023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipids in progression of renal disease.
    Oda H; Keane WF
    Kidney Int Suppl; 1997 Nov; 62():S36-8. PubMed ID: 9350676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein abnormalities in the progression of renal disease.
    Brouhard BH; Cressman MD; Irwin KC; Stowe NT
    Cleve Clin J Med; 1990 Oct; 57(7):599-604. PubMed ID: 2225443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid abnormalities and changes in plasma proteins in glomerular diseases and chronic renal failure.
    Guijarro C; Keane WF
    Curr Opin Nephrol Hypertens; 1993 May; 2(3):372-9. PubMed ID: 7922197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperlipidemia and its management in renal disease.
    Massy ZA; Kasiske BL
    Curr Opin Nephrol Hypertens; 1996 Mar; 5(2):141-6. PubMed ID: 8744535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-transplant hyperlipidemia: mechanisms and management.
    Massy ZA; Kasiske BL
    J Am Soc Nephrol; 1996 Jul; 7(7):971-7. PubMed ID: 8829110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis.
    Kes P
    Acta Med Croatica; 2001; 55(4-5):177-86. PubMed ID: 12398021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of lipid abnormalities in the pathogenesis of chronic, progressive renal disease.
    Kasiske BL; O'Donnell MP; Schmitz PG; Keane WF
    Adv Nephrol Necker Hosp; 1991; 20():109-25. PubMed ID: 2063707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical hyperlipidemia and nephropathy associated with apolipoprotein E homozygosity.
    Ellis D; Orchard TJ; Lombardozzi S; Yunis EJ; McCauley J; Agostini R; Diamond JR
    J Am Soc Nephrol; 1995 Oct; 6(4):1170-7. PubMed ID: 8589283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atherosclerosis and arteriosclerosis of the small vessels in chronic renal insufficiency and after transplantation: lipid factors].
    Boizel R
    Nephrologie; 2000; 21(7):329-32. PubMed ID: 11200602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dyslipidemias in renal diseases: pathogenesis and treatment].
    Cuevas A; Maíz A; Arteaga A
    Rev Med Chil; 1998 Mar; 126(3):315-21. PubMed ID: 9674303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of antilipidemic therapies in chronic renal allograft failure.
    Wanner C; Bartens W; Galle J
    Kidney Int Suppl; 1995 Dec; 52():S60-2. PubMed ID: 8587286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical strategies for arresting progression of renal disease.
    ter Wee PM; Donker AJ
    Kidney Int Suppl; 1992 Oct; 38():S114-20. PubMed ID: 1405361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derangement of lipid metabolism and its management in renal transplant patients.
    Keane WF
    Miner Electrolyte Metab; 1997; 23(3-6):166-9. PubMed ID: 9387109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is hyperlipidemia a factor in the progression of renal failure?].
    Geiger H
    Z Kardiol; 1993; 82 Suppl 4():35-8. PubMed ID: 8147060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of dyslipidemia in chronic kidney disease.
    Stefanovic V; Milojkovic M
    Int J Artif Organs; 2004 Oct; 27(10):821-7. PubMed ID: 15560675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperlipidemia and kidney disease: concepts derived from histopathology and cell biology of the glomerulus.
    Kamanna VS; Roh DD; Kirschenbaum MA
    Histol Histopathol; 1998 Jan; 13(1):169-79. PubMed ID: 9476647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of dyslipidemia in chronic renal failure.
    Toto RD
    Blood Purif; 1996; 14(1):75-82. PubMed ID: 8718569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [What are the possibilities for treatment of hyperlipidemia in kidney insufficiency or in dialysis patients?].
    Grützmacher P; Scheuermann E
    Med Welt; 1982 Jun; 33(24):873-4. PubMed ID: 7109928
    [No Abstract]   [Full Text] [Related]  

  • 20. Dyslipidemia and the progression of renal disease in chronic renal failure patients.
    Cases A; Coll E
    Kidney Int Suppl; 2005 Dec; (99):S87-93. PubMed ID: 16336584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.